NasdaqCM - Delayed Quote USD
NeuroSense Therapeutics Ltd. (NRSNW)
0.2499
+0.0105
+(4.39%)
At close: May 9 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-10,135
-10,135
-8,354
-7,616
-1,539
Investing Cash Flow
1
1
3,468
-3,590
-17
Financing Cash Flow
10,913
10,913
3,975
3,774
11,902
End Cash Position
3,378
3,378
2,640
3,543
11,063
Capital Expenditure
-3
-3
-29
-70
-17
Issuance of Capital Stock
11,304
11,304
4,334
0
9,864
Repayment of Debt
--
--
-80
-79
0
Free Cash Flow
-10,138
-10,138
-8,383
-7,686
-1,556
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ESLAW Estrella Immunopharma, Inc.
0.0807
-4.16%
APLMW Apollomics, Inc.
0.0085
-43.33%
DRTSW Alpha Tau Medical Ltd.
0.2270
-1.30%
CINGW Cingulate Inc.
0.0338
+33.60%
PTIXW Protagenic Therapeutics, Inc.
0.0073
-1.35%
TVGNW Tevogen Bio Holdings Inc.
0.0440
-6.38%
SCNI Scinai Immunotherapeutics Ltd.
2.5800
-6.86%
NRXS NeurAxis, Inc.
2.0000
-8.26%
RVPHW Reviva Pharmaceuticals Holdings, Inc.
0.0500
-16.53%
HUMAW Humacyte, Inc.
0.3000
0.00%